Equities

MANI Inc

MANI Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,786.00
  • Today's Change9.00 / 0.51%
  • Shares traded169.90k
  • 1 Year change-16.33%
  • Beta0.6291
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform4
Hold4
Sell0
Strong Sell0

Share price forecast in JPY

The 5 analysts offering 12 month price targets for Mani Inc have a median target of 2,350.00, with a high estimate of 2,520.00 and a low estimate of 2,000.00. The median estimate represents a 31.58% increase from the last price of 1,786.00.
High41.1%2,520.00
Med31.6%2,350.00
Low12.0%2,000.00

Dividends in JPY

In 2024, MANI Inc reported a dividend of 39.00 JPY, which represents a 11.43% increase over last year. The 7 analysts covering the company expect dividends of 40.29 JPY for the upcoming fiscal year, an increase of 3.30%.
Div growth (TTM)11.43%
More ▼

Earnings history & estimates in JPY

Mani Inc reported annual 2024 earnings of 63.82 per share on Oct 07, 2024.
Average growth rate+17.55%
More ▼

Revenue history & estimates in JPY

Mani, Inc. had 4th quarter 2024 revenues of 6.90m. This missed the 7.17m consensus estimate of the 2 analysts following the company. This was 13.07% above the prior year's 4th quarter results.
Average growth rate+4.43%
Mani, Inc. had revenues for the full year 2024 of 28.51m. This was 16.44% above the prior year's results.
Average growth rate+17.06%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.